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Coeliac disease is a multifactorial disease controlled by
multiple genes and environmental factors. Gluten proteins
of grains are a key environmental factor as the disease goes
in compete remission when gluten proteins are eliminated
from the diet of the patients. The disease can be cate-
gorised as both a food hypersensitivity disorder as well as
an autoimmune disease. Autoantibodies to the enzyme
transglutaminase 2 (TG2) typical of coeliac disease have
higher disease specificity and sensitivity than autoantibo-
dies for any other disorder. Both the autoantibodies and
the disease lesion of the small intestine, characterised
by villous blunting, lamina propriaplasmacytosis and
intraepithelial lymphocytosis, are reversibly dependent gas-
trointestinal exposure to cereal gluten proteins. There is
strong association of coeliac disease with HLA-DQ2.5 and
HLA-DQ8, and the presence of antibodies to TG2 is also
completely dependent on carriage of DQ2.5 or DQ8. In
addition to HLA genes, genome wide association studies
have so far identified 39 non-loci implicated in the disease.
Most of the coeliac disease susceptibility genes are related
to the function of antigen presenting cells and T cells, and
many risk genes are shared with organ specific autoim-
mune diseases.
Research in our laboratory has demonstrated that gluten
reactive CD4 T cells can be found in the lamina propria of
coeliac disease patients, but not healthy controls. These
T cells recognise proline-rich gluten peptides that have
become deamidated by TG2 in the context of DQ2.5 or
DQ8 suggesting that preferential antigen presentation of
as the reason for the HLA association. DQ2.5 and DQ8 is
necessary but not sufficient for coeliac disease develop-
ment, suggesting that activation of gluten reactive CD4
T cells is a key step in the pathogenesis. Many similar, yet
distinct T-cell epitopes exist. The selection of gluten
T-cell epitopes depends on gastrointestinal proteolysis,
TG2 specificity and HLA peptide binding. Intraepithelial
CD8 that bear NK cell receptors are involved in killing of
stressed enterocytes. Although the mechanisms still have
to be elucidated, this process seems to involve the gluten
reactive CD4 T cells. A strong anti-gluten T cell response
require high HLA binding stability of gluten peptides, and
the disparate HLA association between two closely related
HLA molecules, HLA-DQ2.5 and HLA-DQ2.2, seems to
relate to this phenomenon. Finally, among the plasma cells
of the lesion, many of them (10%) are specific for TG2.
The TG2 specific plasma cells utilise a limited repertoire
of variable genes with low degree of somatic mutation.
Thus this antibody response, despite being part of a
chronic condition, bears signs of a primary response.
Together, these findings highlight that coeliac disease
offers unique opportunities for dissection of T cell and B
cell responses that lead to an autoimmune disease.
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